Some residents in D.C.’s Navy Yard neighborhood have begun an aggressive push to lower the District's youth curfew to 8 p.m., or even earlier, after dozens of teenagers, and even younger ...

WASHINGTON — Residents in Navy Yard and city leaders are calling for urgent action after another night of chaos involving large groups of teenagers led to fights, assaults and robberies in the ...

Phylicia Ashley,DCBureauReporter TOPICS: WASHINGTON (7News) — Juveniles in D.C. could lose their privileges in the city after two violent meetups in Navy Yard in three weeks and 7News learned ...

WASHINGTON — As we head into the unofficial start of summer, D.C. officials have announced a new youth curfew at The Wharf in Southwest D.C., aiming to curb recent disruptions caused by large ...

by Lianna Golden TOPICS: WASHINGTON (7News) — 7News On Your Side has been monitoring crime involving youth over the holiday weekend, particularly in the Navy Yard area. A viewer sent 7News a ...

Now this is a fine way for a stock to greet the new year. On the back of a glowing analyst recommendation, Iovance Biotherapeutics's (NASDAQ: IOVA) shares closed Thursday more than 5% higher in price.

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- Biotechnology firm Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is facing a securities class action lawsuit in the Northern District of California ...

On Tuesday, Citizens JMP analysts reiterated a Market Perform rating on Iovance Biotherapeutics stock (NASDAQ: NASDAQ:IOVA), which has declined nearly 80% over the past year. According to ...

WUSA-TV Washington, D.C. Posted: May 24, 2025 | Last updated: May 24, 2025 An increased police presence followed chaotic teen disturbances in Navy Yard, leading to three arrests. Gavin Newsom ...

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ...

Cruz announces that investors with losses related to Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) have opportunity to lead the securities fraud class action lawsuit.

NEW YORK, NY / ACCESS Newswire / June 4, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ ...